Corrigendum: MIS-C Treatment: Is IVIG Always Necessary?(Front. Pediatr. (2021), 9, (753123.), 10.3389/fped.2021.753123)

In the original article, there was an error. Incorrect reference numbers and authors names were cited in the text. “2, 9, 12” has been updated to “2, 11, 13,” “. . . ICU stay (11); Del Borrello et al. and Sacco et al. found. . . ” has been updated to “. . . ICU stay; Son et al. found. . . ,” and “9, 12” has been updated to “2, 11.” A correction has been made to Discussion, Paragraph Number 3: “So far, three real-life retrospective studies have been conducted regarding the use of steroidsto treat MIS-C (2, 11, 13). In two of them, the authors compared the outcomes of the patients treated with steroids and IVIG vs. IVIG alone. Ouldali et al. found that adding MP to IVIG led to a significant decrease of hemodynamic support needs and a reduction in length of ICU stay; Son et al. found that the patients treated with steroids and IVIG had a lower risk of new or persistent cardiovascular dysfunction compared to the ones treated with IVIG alone (2, 11).” The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.